Advances in Ovarian Cancer: Using Genomics and Optimizing Maintenance Therapy
AJMC,
Ovarian cancer remains one of the most challenging malignancies to manage, with high morbidity and mortality rates due to the…
Ovarian cancer remains one of the most challenging malignancies to manage, with high morbidity and mortality rates due to the…
Several practice-changing developments in the treatment of ovarian cancer were seen in 2019, including the results of the…
The cost of managing severe hematologic adverse events (AEs) in US patients with ovarian cancer was lower for those who…
“Overall, the study provided informative data on niraparib’s overall survival in BRCA wild type real world clinical practice…